FDA NDC Directory · JSON-LD · Markdown

Tafinlar

NDC 0078-1154 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Generic namedabrafenib
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA217514
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsDABRAFENIB MESYLATE (10 mg/1)
Marketing started20230316
Package count1

External sources

Source: openFDA. Public-domain (CC0).